Preliminary results of the evaluation of pharmacokinetic profiles in Haemophilia A patients receiving Efanesoctocog Alfa
Stroke Action Plan for Europe 2018-2030 (SAP-E): mid-term review and update.
Vascular calcification inhibitors in chronic kidney disease
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.
In vitro adsorption of direct oral anticoagulants from patient plasma samples
Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
Implementation of laboratory approach for persons with hemophilia requiring DOAC therapy.
Tavapraktikal põhinev tervishoiuteadus: lühiülevaade pragmaatilistest uuringutest
Laboratory Options for Assessing the Effects of Direct Oral Anticoagulants in Estonia
Higher versus lower mean arterial blood pressure after cardiac arrest and resuscitation (MAP-CARE): A protocol for a randomized clinical trial
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
The European Program for Prevention (EPP) – Implementing Proven Preventing Measures Now!
Euroopa düslipideemia ravijuhend 2025: fookuses on kaasaegsed efektiivsed ravivõimalused
Low-titer group O whole blood implementation in a tertiary care hospital in Estonia.